title: Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.
abstract: Germline mutations in the succinate dehydrogenase (SDH) (mitochondrial respiratory chain complex II) subunit B gene, SDHB, cause susceptibility to head and neck paraganglioma and phaeochromocytoma. Previously, we did not identify somatic SDHB mutations in sporadic phaeochromocytoma, but SDHB maps to 1p36, a region of frequent loss of heterozygosity (LOH) in neuroblastoma as well. Hence, to evaluate SDHB as a candidate neuroblastoma tumour suppressor gene (TSG) we performed mutation analysis in 46 primary neuroblastomas by direct sequencing, but did not identify germline or somatic SDHB mutations. As TSGs such as RASSF1A are frequently inactivated by promoter region hypermethylation, we designed a methylation-sensitive PCR-based assay to detect SDHB promoter region methylation. In 21% of primary neuroblastomas and 32% of phaeochromocytomas (32%) methylated (and unmethylated) alleles were detected. Although promoter region methylation was also detected in two neuroblastoma cell lines, this was not associated with silencing of SDHB expression, and treatment with a demethylating agent (5-azacytidine) did not increase SDH activity. These findings suggest that although germline SDHB mutations are an important cause of phaeochromocytoma susceptibility, somatic inactivation of SDHB does not have a major role in sporadic neural crest tumours and SDHB is not the target of 1p36 allele loss in neuroblastoma and phaeochromocytoma.
authors.affiliation: Section of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, The Medical School, Edgbaston, Birmingham B15 2TT, UK.
authors.forename: D
authors.initials: D
authors.lastname: Astuti
authors.forename: M
authors.initials: M
authors.lastname: Morris
authors.forename: C
authors.initials: C
authors.lastname: Krona
authors.forename: F
authors.initials: F
authors.lastname: Abel
authors.forename: D
authors.initials: D
authors.lastname: Gentle
authors.forename: T
authors.initials: T
authors.lastname: Martinsson
authors.forename: P
authors.initials: P
authors.lastname: Kogner
authors.forename: H P H
authors.initials: HP
authors.lastname: Neumann
authors.forename: R
authors.initials: R
authors.lastname: Voutilainen
authors.forename: C
authors.initials: C
authors.lastname: Eng
authors.forename: P
authors.initials: P
authors.lastname: Rustin
authors.forename: F
authors.initials: F
authors.lastname: Latif
authors.forename: E R
authors.initials: ER
authors.lastname: Maher
mesh_terms: D001483:Base Sequence; D045744:Cell Line, Tumor; D019175:DNA Methylation; D020868:Gene Silencing; D006801:Humans; D007506:Iron-Sulfur Proteins; D019656:Loss of Heterozygosity; D008969:Molecular Sequence Data; D009154:Mutation; D009432:Neural Crest; D009447:Neuroblastoma / Q000235:genetics*; D010673:Pheochromocytoma / Q000235:genetics*; D011401:Promoter Regions, Genetic; D021122:Protein Subunits / Q000235:genetics*; D013385:Succinate Dehydrogenase / Q000235:genetics*
chemical_list: D007506:Iron-Sulfur Proteins; D021122:Protein Subunits; C108095:SDHB protein, human; D013385:Succinate Dehydrogenase